Study Data Shows How UBX1325 Improves Visual Acuity in Diabetic Macular Edema
In a late April 2023 news release, biotechnology company UNITY Biotechnology, Inc. ("UNITY") shared that the company had observed positive long-term follow-up data from the Phase 2 BEHOLD trial. Within…